Suppr超能文献

一种新型川芎嗪衍生物通过阻断N-甲基-D-天冬氨酸受体对原代神经元谷氨酸诱导的兴奋毒性具有预防性保护作用。

A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of -Methyl-D-aspartate Receptor.

作者信息

Hu Shengquan, Hu Huihui, Mak Shinghung, Cui Guozhen, Lee Mingyuen, Shan Luchen, Wang Yuqiang, Lin Huangquan, Zhang Zaijun, Han Yifan

机构信息

Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases, Jinan University College of Pharmacy, Guangzhou, China.

Department of Applied Biology and Chemical Technology, Institute of Modern Chinese Medicine, The Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Front Pharmacol. 2018 Feb 12;9:73. doi: 10.3389/fphar.2018.00073. eCollection 2018.

Abstract

The over-activation of NMDA receptor via the excessive glutamate is believed to one of the most causal factors associated with Alzheimer's disease (AD), a progressive neurodegenerative brain disorder. Molecules that could protect against glutamate-induced neurotoxicity may hold therapeutic values for treating AD. Herein, the neuroprotective mechanisms of dimeric DT-010, a novel derivative of naturally occurring danshensu and tetramethylpyrazine, were investigated using primary rat cerebellar granule neurons (CGNs) and hippocampal neurons. It was found that DT-010 (3-30 μM) markedly prevented excitotoxicity of CGNs caused by glutamate, as evidenced by the promotion of neuronal viability as well as the reversal of abnormal morphological changes. While its parent molecules did not show any protective effects even when their concentration reached 50 μM. Additionally, DT-010 almost fully blocked intracellular accumulation of reactive oxygen species caused by glutamate and exogenous oxidative stimulus. Moreover, Western blot results demonstrated that DT-010 remarkably attenuated the inhibition of pro-survival PI3K/Akt/GSK3β pathway caused by glutamate. Ca imaging with Fluo-4 fluorescence analysis further revealed that DT-010 greatly declined glutamate-induced increase in intracellular Ca. Most importantly, with the use of whole-cell patch clamp electrophysiology, DT-010 directly inhibited NMDA-activated whole-cell currents in primary hippocampal neurons. Molecular docking simulation analysis further revealed a possible binding mode that inhibited NMDA receptor at the ion channel, showing that DT-010 favorably binds to Asn602 of NMDA receptor via arene hydrogen bond. These results suggest that DT-010 could be served as a novel NMDA receptor antagonist and protect against glutamate-induced excitotoxicity from blocking the upstream NMDA receptors to the subsequent Ca influx and to the downstream GSK3β cascade.

摘要

通过过量谷氨酸导致的NMDA受体过度激活被认为是与阿尔茨海默病(AD)相关的最主要病因之一,AD是一种进行性神经退行性脑部疾病。能够预防谷氨酸诱导的神经毒性的分子可能对治疗AD具有治疗价值。在此,使用原代大鼠小脑颗粒神经元(CGNs)和海马神经元研究了天然存在的丹参素和川芎嗪的新型衍生物二聚体DT-010的神经保护机制。发现DT-010(3-30μM)显著预防了谷氨酸引起的CGNs兴奋性毒性,这通过促进神经元活力以及逆转异常形态变化得到证明。而其母体分子即使浓度达到50μM也未显示出任何保护作用。此外,DT-010几乎完全阻断了谷氨酸和外源性氧化刺激引起的细胞内活性氧的积累。此外,蛋白质印迹结果表明,DT-010显著减弱了谷氨酸对促生存PI3K/Akt/GSK3β通路的抑制作用。用Fluo-4荧光分析进行的钙成像进一步显示,DT-010大大降低了谷氨酸诱导的细胞内钙增加。最重要的是,使用全细胞膜片钳电生理学,DT-010直接抑制了原代海马神经元中NMDA激活的全细胞电流。分子对接模拟分析进一步揭示了一种可能的结合模式,即在离子通道处抑制NMDA受体,表明DT-010通过芳烃氢键与NMDA受体的Asn602有利地结合。这些结果表明,DT-010可以作为一种新型的NMDA受体拮抗剂,通过阻断上游NMDA受体到随后的钙内流以及下游GSK3β级联反应来预防谷氨酸诱导的兴奋性毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ae/5816056/2f55faeae93c/fphar-09-00073-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验